IST:GENIL's Return-on-Tangible-Asset is ranked better than 58.18% of 1009
companies
in the Drug Manufacturers industry
Industry Median: 3.16
vs IST:GENIL: 4.97
Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Gen Ilac Veglik Urunlerinayi ve Ticaret AS Return-on-Tangible-Asset Related Terms
Gen Ilac Veglik Urunlerinayi ve Ticaret AS Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gen Ilac Veglik Urunlerinayi ve Ticaret AS Return-on-Tangible-Asset Chart
Gen Ilac Veglik Urunlerinayi ve Ticaret AS Annual Data
IST:GENIL vs ZTS, UTHR, VTRS: Return-on-Tangible-Asset Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gen Ilac Veglik Urunlerinayi ve Ticaret AS Return-on-Tangible-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 7.83% mean?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) has a Return-on-Tangible-Asset of 7.83% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Gen Ilac Veglik Urunlerinayi ve Ticaret AS and its competitors. This is 34% below median its historical median of 11.95. Over the past decade, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Return-on-Tangible-Asset has ranged from 1.44 to 29.41. According to the industry distribution chart, Gen Ilac Veglik Urunlerinayi ve Ticaret AS ranks #422 out of 1009 companies in the Drug Manufacturers industry, placing it in the top 41.8%.
Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Return-on-Tangible-Asset too high?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Return-on-Tangible-Asset of 7.83% is 34% below median its 10-year median of 11.95. Over the past 10 years, this metric has ranged from a low of 1.44 to a high of 29.41. The Drug Manufacturers industry median Return-on-Tangible-Asset is 3.16. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's value of 7.83% is 147.8% above this industry median. Based on the distribution chart, Gen Ilac Veglik Urunlerinayi ve Ticaret AS ranks #422 out of 1009 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Gen Ilac Veglik Urunlerinayi ve Ticaret AS has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Return-on-Tangible-Asset compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Gen Ilac Veglik Urunlerinayi ve Ticaret AS ranks #422 out of 1009 companies for Return-on-Tangible-Asset. This puts Gen Ilac Veglik Urunlerinayi ve Ticaret AS in the upper half of its industry. The industry median Return-on-Tangible-Asset is 3.16. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's value of 7.83% is 147.8% above this benchmark. Historically, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's own Return-on-Tangible-Asset has ranged from 1.44 to 29.41 over the past decade. While the company's 10-year median is 11.95 vs. the industry median of 3.16, Gen Ilac Veglik Urunlerinayi ve Ticaret AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Drug Manufacturers company?
The median Return-on-Tangible-Asset among Drug Manufacturers companies is 3.16, based on 1,009 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Return-on-Tangible-Asset of 7.83% is 147.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Gen Ilac Veglik Urunlerinayi ve Ticaret AS and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Asset is 3.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Return-on-Tangible-Asset is 7.83%, which is 34% below median its own 10-year median of 11.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) is currently considered Modestly Overvalued. The stock's GF Value™ is ₺8.17, compared to a current price of ₺9.10 — trading 11.4% above its estimated fair value. The current Return-on-Tangible-Asset is 7.83%, which is 34% below median its 10-year median of 11.95 and 147.8% above the Drug Manufacturers industry median of 3.16. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL), the current Return-on-Tangible-Asset is 7.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Overvalued in 2026?
Based on GuruFocus' analysis, Gen Ilac Veglik Urunlerinayi ve Ticaret AS stock appears to be overvalued.
The current stock price of ₺9.10 is trading 11.4% above its estimated GF Value™ of ₺8.17.
GuruFocus considers Gen Ilac Veglik Urunlerinayi ve Ticaret AS to be Modestly Overvalued.
Key valuation signals for IST:GENIL:
Return-on-Tangible-Asset: 7.83% (34% below median its 10-year median of 11.95)
GF Value™: ₺8.17 vs. price of ₺9.10 (11.4% above fair value)
Industry Position: 147.8% above the Drug Manufacturers median (#422 of 1009)
No single metric tells the full story. See the IST:GENIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gen Ilac Veglik Urunlerinayi ve Ticaret AS Business Description
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.
86GF Score
Get the complete analysis for IST:GENIL
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:GENIL has been successfully added to your 
